Related Experiment Videos
DNA changes during blastic transformation in chronic granulocytic leukemia
B G Williams1, H Kronenberg, R J Trent
1Molecular Biology Laboratory, University of Sydney.
Pathology
|July 1, 1987
Summary
Immunoglobulin and T cell receptor gene mapping in chronic granulocytic leukemia patients revealed that 20% transformed to lymphoblastic leukemia. DNA changes did not predict this transformation or treatment response.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Chronic granulocytic leukemia (CGL) is a myeloproliferative neoplasm.
- Understanding genetic alterations is crucial for predicting disease progression and treatment outcomes.
- Immunoglobulin (IG) and T cell receptor (TCR) gene rearrangements are key markers in lymphoid malignancies.
Purpose of the Study:
- To investigate IG and TCR gene mapping in patients with chronic granulocytic leukemia.
- To determine if genetic changes correlate with disease phase and transformation.
- To assess the predictive value of DNA changes for blastic transformation and treatment response.
Main Methods:
- Gene mapping of immunoglobulin and T cell receptor loci.
- Analysis of DNA in patients during chronic and blastic phases of CGL.
- Evaluation of 20% of patients for lymphoblastic transformation.
Main Results:
- Twenty percent of patients with CGL underwent lymphoblastic transformation.
- No significant correlation was found between observed DNA changes and the prediction of blastic transformation.
- DNA alterations did not predict favorable responses to vincristine and prednisone treatment.
Conclusions:
- IG and TCR gene mapping can be utilized in CGL.
- Observed DNA changes in CGL lack predictive power for blastic transformation.
- Current DNA markers do not predict treatment efficacy with vincristine and prednisone in CGL.